ACELYRIN Appoints Paul M. Peloso, MD, as Chief Medical Officer

LOS ANGELES: LOS ANGELES, May 25, 2021 /PRNewswire/ -- ACELYRIN, INC., a biopharma company focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of promising drug candidates, today announced it has appointed Paul M. Peloso, MD, as the Company's first chief medical officer....

Click to view original post